| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |